Cancer Institute– A national cancer institute
designated cancer center

Lauren B. Gerson MD, MSc

Back to Profile

Publication Details

  • Development of a refractory gastro-oesophageal reflux score using an administrative claims database.

    Gerson LB, Bonafede M, Princic N, Gregory C, Farr A, Balu S. Aliment Pharmacol Ther. 2011; 34 (5): 555-67

    Approximately one-third of gastro-oesophageal reflux disease (GERD) patients demonstrate refractory symptoms following treatment with proton pump inhibitor (PPI) therapy.

    PubMedID: 21714794

Stanford Medicine Resources:

Footer Links: